Cargando…
PSAT251 Examination of TRH test in Central Hypothyroidism due to Non-Functional Pituitary Adenoma
OBJECTIVES: There is a little evidence for the TRH test criteria in the diagnosis of Central Hypothyroidism (CeH). Therefore, we investigated the significance of the TRH test for Central Hypothyroidism due to Non-Functional Pituitary Adenoma. METHODS: 107 cases of Non-functional pituitary adenoma (N...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625588/ http://dx.doi.org/10.1210/jendso/bvac150.1669 |
_version_ | 1784822536106672128 |
---|---|
author | Buyandalai, Battsetseg Takamizawa, Tetsuya Horiguchi, Kazuhiko Yoshioka, Masayuki Nishikido, Ayaka Toki, Akiko Ishida, Emi Yoshino, Satoshi Matsumoto, Shunichi Yamada, Eijiro Ozawa, Atsushi Yamaguchi, Rei Tosaka, Masahiko Yamada, Shozo Yamada, Masanobu |
author_facet | Buyandalai, Battsetseg Takamizawa, Tetsuya Horiguchi, Kazuhiko Yoshioka, Masayuki Nishikido, Ayaka Toki, Akiko Ishida, Emi Yoshino, Satoshi Matsumoto, Shunichi Yamada, Eijiro Ozawa, Atsushi Yamaguchi, Rei Tosaka, Masahiko Yamada, Shozo Yamada, Masanobu |
author_sort | Buyandalai, Battsetseg |
collection | PubMed |
description | OBJECTIVES: There is a little evidence for the TRH test criteria in the diagnosis of Central Hypothyroidism (CeH). Therefore, we investigated the significance of the TRH test for Central Hypothyroidism due to Non-Functional Pituitary Adenoma. METHODS: 107 cases of Non-functional pituitary adenoma (NFPA) in Gunma University Hospital Neurosurgery and Toranomon Hospital Intercerebral Pituitary Surgery, between 2007 to 2020 are studied. Subjects divided into CeH group (n = 19) with FT4 below the reference value and a normal group (n = 88). Serum TSH level was determined before (basal-TSH value) and 30, 60, 120 minutes after TRH administration. Peak-TSH value, delayed and prolonged responses were analyzed. A peak-TSH occurring at 60 minutes or later was considered as a delayed response. If 120-minutes TSH value to peak-TSH value ratio is equal to or higher than 0.6 was considered as a prolonged response. RESULTS: The basal-TSH was higher in the CeH group than in the normal group (median 2.7 vs. 1.5μIU/mL) (p <0.01). There was no difference between two groups, in both 30-minute value and the peak value. Delayed response occurred in 10/19 (53%) in the CeH group, and 18/88 (20%) in the normal group (p < 0.01). Prolonged response occurred at a higher rate of 15/19 (79%) in the CeH group, while in 23/88 (26%) in the normal group (p <0.01). AUC was maximum when prolonged response (120-minute value to peak value ratio) is equal to or lower than 0.65. CONCLUSION: In central hypothyroidism due to Non-Functional Pituitary Adenoma, the basal-TSH value does not usually decrease, but rather be higher value within the reference range. 30-minute value or peak value was not useful in diagnosis, yet the prolonged response was more significant. Central Hypothyroidism in Non-Functional Pituitary Adenoma, can be diagnosed with sensitivity of 79% and specificity of 78% when the 120-minute value to peak value ratio is equal to or lower than 0.65. Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m. |
format | Online Article Text |
id | pubmed-9625588 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-96255882022-11-14 PSAT251 Examination of TRH test in Central Hypothyroidism due to Non-Functional Pituitary Adenoma Buyandalai, Battsetseg Takamizawa, Tetsuya Horiguchi, Kazuhiko Yoshioka, Masayuki Nishikido, Ayaka Toki, Akiko Ishida, Emi Yoshino, Satoshi Matsumoto, Shunichi Yamada, Eijiro Ozawa, Atsushi Yamaguchi, Rei Tosaka, Masahiko Yamada, Shozo Yamada, Masanobu J Endocr Soc Thyroid OBJECTIVES: There is a little evidence for the TRH test criteria in the diagnosis of Central Hypothyroidism (CeH). Therefore, we investigated the significance of the TRH test for Central Hypothyroidism due to Non-Functional Pituitary Adenoma. METHODS: 107 cases of Non-functional pituitary adenoma (NFPA) in Gunma University Hospital Neurosurgery and Toranomon Hospital Intercerebral Pituitary Surgery, between 2007 to 2020 are studied. Subjects divided into CeH group (n = 19) with FT4 below the reference value and a normal group (n = 88). Serum TSH level was determined before (basal-TSH value) and 30, 60, 120 minutes after TRH administration. Peak-TSH value, delayed and prolonged responses were analyzed. A peak-TSH occurring at 60 minutes or later was considered as a delayed response. If 120-minutes TSH value to peak-TSH value ratio is equal to or higher than 0.6 was considered as a prolonged response. RESULTS: The basal-TSH was higher in the CeH group than in the normal group (median 2.7 vs. 1.5μIU/mL) (p <0.01). There was no difference between two groups, in both 30-minute value and the peak value. Delayed response occurred in 10/19 (53%) in the CeH group, and 18/88 (20%) in the normal group (p < 0.01). Prolonged response occurred at a higher rate of 15/19 (79%) in the CeH group, while in 23/88 (26%) in the normal group (p <0.01). AUC was maximum when prolonged response (120-minute value to peak value ratio) is equal to or lower than 0.65. CONCLUSION: In central hypothyroidism due to Non-Functional Pituitary Adenoma, the basal-TSH value does not usually decrease, but rather be higher value within the reference range. 30-minute value or peak value was not useful in diagnosis, yet the prolonged response was more significant. Central Hypothyroidism in Non-Functional Pituitary Adenoma, can be diagnosed with sensitivity of 79% and specificity of 78% when the 120-minute value to peak value ratio is equal to or lower than 0.65. Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m. Oxford University Press 2022-11-01 /pmc/articles/PMC9625588/ http://dx.doi.org/10.1210/jendso/bvac150.1669 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Thyroid Buyandalai, Battsetseg Takamizawa, Tetsuya Horiguchi, Kazuhiko Yoshioka, Masayuki Nishikido, Ayaka Toki, Akiko Ishida, Emi Yoshino, Satoshi Matsumoto, Shunichi Yamada, Eijiro Ozawa, Atsushi Yamaguchi, Rei Tosaka, Masahiko Yamada, Shozo Yamada, Masanobu PSAT251 Examination of TRH test in Central Hypothyroidism due to Non-Functional Pituitary Adenoma |
title | PSAT251 Examination of TRH test in Central Hypothyroidism due to Non-Functional Pituitary Adenoma |
title_full | PSAT251 Examination of TRH test in Central Hypothyroidism due to Non-Functional Pituitary Adenoma |
title_fullStr | PSAT251 Examination of TRH test in Central Hypothyroidism due to Non-Functional Pituitary Adenoma |
title_full_unstemmed | PSAT251 Examination of TRH test in Central Hypothyroidism due to Non-Functional Pituitary Adenoma |
title_short | PSAT251 Examination of TRH test in Central Hypothyroidism due to Non-Functional Pituitary Adenoma |
title_sort | psat251 examination of trh test in central hypothyroidism due to non-functional pituitary adenoma |
topic | Thyroid |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625588/ http://dx.doi.org/10.1210/jendso/bvac150.1669 |
work_keys_str_mv | AT buyandalaibattsetseg psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma AT takamizawatetsuya psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma AT horiguchikazuhiko psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma AT yoshiokamasayuki psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma AT nishikidoayaka psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma AT tokiakiko psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma AT ishidaemi psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma AT yoshinosatoshi psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma AT matsumotoshunichi psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma AT yamadaeijiro psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma AT ozawaatsushi psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma AT yamaguchirei psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma AT tosakamasahiko psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma AT yamadashozo psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma AT yamadamasanobu psat251examinationoftrhtestincentralhypothyroidismduetononfunctionalpituitaryadenoma |